ATON PORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 2.76 $ 0.15 (5.45 %)    

Thursday, 20-Nov-2025 13:11:55 EST
QQQ $ 595.05 $ -16.62 (-2.72 %)
DIA $ 461.18 $ -5.50 (-1.18 %)
SPY $ 660.42 $ -12.48 (-1.85 %)
TLT $ 89.09 $ 0.10 (0.11 %)
GLD $ 373.53 $ -1.65 (-0.45 %)
$ 2.8
$ 2.75
$ 2.76 x 50
$ 2.87 x 280
$ 2.90 - $ 2.90
$ 2.72 - $ 15.82
42,861
na
6.38M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON) ("AlphaTON" or the "Company"), a specialized digital asset technology comp...

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON), a leading digital asset company focused on growing the Telegram ecosystem, today announce...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON) – AlphaTON Capital, a leading investm...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON), a specialized digital asset treasury...

Core News & Articles

AlphaTON Capital (NASDAQ:ATON), a leading digital asset infrastructure company focused on Telegram and the TON blockchain ecosy...

Core News & Articles

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyn...

Core News & Articles

Telegram's more than 1 billion monthly active users represent the world's largest untapped market for AI agents that ac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION